Prime medicine announces breakthrough clinical data showing rapid restoration of dhr positivity after single infusion of pm359, an investigational prime editor for chronic granulomatous disease

-- first ever clinical data supporting safety and efficacy of prime editing in humans -- -- initial data from first patient dosed in phase 1/2 trial finds single dose of pm359 led to 58% dhr positivity by day 15 and 66% by day 30, well above levels believed to be potentially curative --
DHR Ratings Summary
DHR Quant Ranking